FUSN Annual CAPEX
$3.89 M
+$1.75 M+81.61%
31 December 2023
Summary:
As of January 27, 2025, FUSN annual capital expenditures is $3.89 million, with the most recent change of +$1.75 million (+81.61%) on December 31, 2023.FUSN CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FUSN Quarterly CAPEX
N/A
31 March 2024
Summary:
FUSN quarterly capital expenditures is not available.FUSN Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FUSN TTM CAPEX
N/A
31 March 2024
Summary:
FUSN TTM capital expenditures is not available.FUSN TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FUSN CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +81.6% | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
FUSN CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high |
Fusion Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $3.89 M(+81.6%) | - | - |
| Sept 2023 | - | $473.00 K(-33.4%) | $3.36 M(+8.1%) |
| June 2023 | - | $710.00 K(-41.9%) | $3.10 M(+12.1%) |
| Mar 2023 | - | $1.22 M(+28.7%) | $2.77 M(+29.3%) |
| Dec 2022 | $2.14 M(+43.7%) | $950.00 K(+327.9%) | $2.14 M(+23.8%) |
| Sept 2022 | - | $222.00 K(-40.8%) | $1.73 M(+3.7%) |
| June 2022 | - | $375.00 K(-37.0%) | $1.67 M(+11.1%) |
| Mar 2022 | - | $595.00 K(+10.6%) | $1.50 M(+0.7%) |
| Dec 2021 | $1.49 M | $538.00 K(+236.2%) | $1.49 M(+47.2%) |
| Sept 2021 | - | $160.00 K(-23.4%) | $1.01 M(-34.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $209.00 K(-64.2%) | $1.53 M(+2.7%) |
| Mar 2021 | - | $584.00 K(+873.3%) | $1.49 M(+32.9%) |
| Dec 2020 | - | $60.00 K(-91.2%) | $1.12 M(-4.7%) |
| Sept 2020 | - | $681.00 K(+305.4%) | $1.18 M(+71.6%) |
| June 2020 | - | $168.00 K(-21.5%) | $687.00 K(+8.9%) |
| Mar 2020 | - | $214.00 K(+84.5%) | $631.00 K(+38.4%) |
| Dec 2019 | - | $116.00 K(-38.6%) | $456.00 K(+34.1%) |
| Sept 2019 | - | $189.00 K(+68.8%) | $340.00 K(+125.2%) |
| June 2019 | - | $112.00 K(+187.2%) | $151.00 K(+287.2%) |
| Mar 2019 | - | $39.00 K | $39.00 K |
FAQ
- What is Fusion Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for Fusion Pharmaceuticals?
- What is the all time high TTM CAPEX for Fusion Pharmaceuticals?
What is Fusion Pharmaceuticals annual capital expenditures?
The current annual CAPEX of FUSN is $3.89 M
What is the all time high annual CAPEX for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high annual capital expenditures is $3.89 M
What is Fusion Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, FUSN annual capital expenditures has changed by +$1.75 M (+81.61%)
What is the all time high quarterly CAPEX for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high quarterly capital expenditures is $1.22 M
What is the all time high TTM CAPEX for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high TTM capital expenditures is $3.36 M